Search Results - "Stirk L"

A 5-wk endurance exercise programme affects glycaemic regulation in pre-diabetic, but not diabetic rats.

Authors: Peters-Futre, E. Naidu, P. Stirk, L. et al.

Source: Journal of Science & Medicine in Sport. Jan2017 Supplement 1, Vol. 20, pe42-e43.

Incidence and prevalence of diseases.

Authors: Golder S Light K Stirk L

Source: Journal of Health Services Research & Policy. Jan2008, Vol. 13 Issue 1, p53-54. 2p.

Effectiveness and cost-effectiveness of height-screening programmes during the primary school years: a systematic review.

Authors: Fayter D Nixon J Hartley S et al.

Source: Archives of Disease in Childhood. Apr2008, Vol. 93 Issue 4, p278-284. 7p.

PRM77 - Not All Cochrane Reviews Are Good Quality Systematic Reviews.

Authors: Deshpande, S Misso, K Westwood, M et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA371-A371. 1p.

PCV21 - Relationship between Lipoprotein(A) and Cardiovascular Events: A Systematic Review.

Authors: Quek, RG Forbes, CA Deshpande, S et al.

Source: Value in Health. May2016, Vol. 19 Issue 3, pA43-A43. 1p.

Newborn screening for severe combined immunodeficiency in the NHS newborn blood spot screening programme: a systematic review.

Authors: Westwood M Emerson J Armstrong N et al.

Source: Health technology assessment (Winchester, England) [Health Technol Assess] 2026 Jun; Vol. 30 (45), pp. 1-118.

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: NIHR Journals Library Country of Publication: England NLM ID: 9706284 Publication Model: Print Cited Medium: Internet ISSN: 2046-4924 (Electronic) Linking ISSN: 13665278 NLM ISO Abbreviation: Health Technol Assess Subsets: MEDLINE

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma.

Authors: Scholte M Fernández Coves A Yang H et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2026 May; Vol. 44 (5), pp. 509-513. Date of Electronic Publication: 2026 Jan 25.

Publication Type: Journal Article

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE; In Process

When Evidence Falls Short-Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal.

Authors: Corro Ramos I O'Meara S Patel M et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2025 Aug; Vol. 43 (8), pp. 845-848. Date of Electronic Publication: 2025 May 07.

Publication Type: Journal Article

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE; In Process

Reply to Comment on "Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective".

Authors: Poley MJ Armstrong N Yang H et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2026 Jan; Vol. 44 (1), pp. 99-100. Date of Electronic Publication: 2025 Oct 30.

Publication Type: Letter

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE; In Process

Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective.

Authors: Poley MJ Armstrong N Yang H et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2025 Oct; Vol. 43 (10), pp. 1165-1169. Date of Electronic Publication: 2025 Jul 23.

Publication Type: Editorial

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE; In Process

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

Authors: Scholte M Ramaekers B Danopoulos E et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2024 Aug; Vol. 42 (8), pp. 829-832. Date of Electronic Publication: 2024 May 08.

Publication Type: Journal Article

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE

Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors: Otten T Riemsma R Wijnen B et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2023 Nov; Vol. 41 (11), pp. 1551.

Publication Type: Published Erratum

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: In Process

Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors: van Asselt ADI Armstrong N Kimman M et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2023 Mar; Vol. 41 (3), pp. 239-251. Date of Electronic Publication: 2023 Feb 01.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics

Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors: Wijnen B Witlox W Wolff R et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2023 Jan; Vol. 41 (1), pp. 33-42. Date of Electronic Publication: 2022 Oct 27.

Publication Type: Systematic Review; Journal Article; Research Support, Non-U.S. Gov't; Network Meta-Analysis

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics

Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors: Otten T Riemsma R Wijnen B et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2022 Sep; Vol. 40 (9), pp. 851-861. Date of Electronic Publication: 2022 Jul 08.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics

Systematic review search methods evaluated using the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses and the Risk Of Bias In Systematic reviews tool.

Authors: de Kock S Stirk L Ross J et al.

Source: International journal of technology assessment in health care [Int J Technol Assess Health Care] 2020 Dec 07; Vol. 37, pp. e18. Date of Electronic Publication: 2020 Dec 07.

Publication Type: Journal Article

Journal Info: Publisher: Cambridge University Press Country of Publication: England NLM ID: 8508113 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-6348 (Electronic) Linking ISSN: 02664623 NLM ISO Abbreviation: Int J Technol Assess Health Care Subsets: MEDLINE

Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors: Witlox WJA van Asselt ADI Wolff R et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2020 Apr; Vol. 38 (4), pp. 317-324.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics

A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.

Authors: Ryder S Fox K Rane P et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2019 Jul; Vol. 37 (7), pp. 895-919.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics

Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors: Grimm SE Armstrong N Ramaekers BLT et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2019 May; Vol. 37 (5), pp. 655-667.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.

Authors: Büyükkaramikli NC de Groot S Fayter D et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2018 Feb; Vol. 36 (2), pp. 145-159.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics